GCP Clinical Research (GCP), located in beautiful Tampa, Florida, specializes in conducting Clinical Trials on investigational medications being developed by pharmaceutical and biotech companies. The foundation of our research clinic is built on a 30-year-old multi-specialty practice, LoCicero Medical Group with a patient database of over 100,000. This partnership with LoCicero Medical Group combined with the philanthropic efforts of our research patients make new treatment modalities possible and it is only through their efforts that we are able to Advance medical discoveries.
At GCP, our dynamic, caring, bilingual research team also has over 100 years experience involving more than 200 Phase I-IV Clinical Trials. We are committed to the Advancement of Medicine by ensuring that responsible and reliable clinical research results are achieved. The safety and protection of our patients is paramount to our work. We understand that the decision to participate in a clinical trial is a very personal one that requires a level of trust. We offer 24/7 patient support throughout the entire clinical trial process, from pre-screening and enrollment to completion.
Close proximity to Memorial Hospital of Tampa with its state-of-the-art 18-bed emergency room provides a convenient advantage, and our 6,000 square foot clinic provides on-site diagnostic and testing services, which reduces the number of patient visits and wait times. Our diagnostic and lab services are as follows:
18 Examination Rooms • COLA/CLIA certified laboratory • On-Site Pharmacy
IV Infusion pumps • DEXA scan • Ultrasound • Computerized ECG machines
Echocardiography • Pulmonary Function Testing • Mammography
X-ray • MRI • CT • PET Scan • Wi-Fi access throughout
Temperature-controlled drug storage areas
CURRENT CLINICAL TRIALS
The Melanoma Clinical Trial conducted by our subsidiary, GCP Cancer Research, LLC, injects a one-time vaccine into a melanoma lesion on the skin. This triggers the immune system to attack the cancer cells. In pre-clinical trials, this has proven to be 98% curative. FIND OUT IF YOU QUALIFY
Squamous Cell Carcinoma. This Clinical Trial, conducted by our subsidiary, GCP Cancer Research, LLC, presents a one-time vaccine injected into the lesion, triggering the immune system to attack the cancer cells. In pre-clinical trials, this has proven to be 98% curative. FIND OUT IF YOU QUALIFY
Endometriosis is a painful disorder in which the tissue that lines the inside of the uterus (the endometrium) grows outside the uterus. Endometriosis most commonly involves the ovaries, fallopian tubes and the tissue lining the area of the pelvis. FIND OUT IF YOU QUALIFY
GOUT is more common in men, in women after menopause, and people who drink alcohol. This Clinical Trial treatment is an FDA approved medication combined with a 2nd FDA approved medication to achieve maximum results. FIND OUT IF YOU QUALIFY
Hot Flashes are the most common symptom of menopause and perimenopause. Standard treatment is hormone replacement therapy or antidepressants, which still raises concerns. This Clinical Trial treatment is neither hormone nor antidepressant. FIND OUT IF YOU QUALIFY
Ulcerative Colitis is a disease of the large intestine/colon in which the lining becomes inflamed and develops tiny sores or ulcers. This Clinical Trial uses a FDA approved medication combined with a 2nd FDA approved medication to achieve maximum results. FIND OUT IF YOU QUALIFY